| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/22/2009 | US20090022658 Modified antibodies and methods of use |
| 01/22/2009 | US20090022655 boron neutron capture therapy, attaching antibody (IgG) cell-targeting species to BN nanostructures to form composite, administering to target tumors, activating boron in composite; indirect source of radiation therapy, delivery vehicles for radio- and chemo-therapeutic materials, imaging agents |
| 01/22/2009 | DE102007032977A1 Neue Cyclische Amide, Verfahren zu deren Herstellung und ihre Verwendung Novel cyclic amides, process for their preparation and their use |
| 01/22/2009 | DE102007032799A1 New sugar-containing polypyridine metal complexes e.g. useful as fluorescence markers in biological systems or for treating abnormal cells |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | CA2694475A1 Quinazolinamide derivatives |
| 01/22/2009 | CA2693926A1 Dna-pk inhibitors |
| 01/22/2009 | CA2693880A1 Pyrimidine derivatives 934 |
| 01/22/2009 | CA2693863A1 Engineered anti-alpha v- integrin hybrid antibodies |
| 01/22/2009 | CA2693862A1 Specific therapy and medicament using integrin ligands for treating cancer |
| 01/22/2009 | CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | CA2693473A1 Thiadiazole modulators of pkb |
| 01/22/2009 | CA2693255A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | CA2693232A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | CA2693057A1 Oral formulations for picoplatin |
| 01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692819A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | CA2692713A1 Heterocyclic modulators of pkb |
| 01/22/2009 | CA2691847A1 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/22/2009 | CA2691127A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | CA2690761A1 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 01/22/2009 | CA2690619A1 Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |
| 01/21/2009 | EP2017621A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/21/2009 | EP2017343A2 Protein A based binding domains with desirable activities |
| 01/21/2009 | EP2017341A2 Apo-2 ligand |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017281A1 Toll-like receptor 9 agonists |
| 01/21/2009 | EP2017279A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity |
| 01/21/2009 | EP2017278A1 Dihydropyrazolopyrimidinone derivative |
| 01/21/2009 | EP2017277A1 Thiophene-imidazopyridines |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016952A2 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 01/21/2009 | EP2016948A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 01/21/2009 | EP2016944A2 Angiogenesis inhibitor containing a derivative of rifampicin |
| 01/21/2009 | EP2016930A2 A cell therapy method for the treatment of tumors |
| 01/21/2009 | EP2016080A1 Dihydropyrazolopyrimidinone derivatives |
| 01/21/2009 | EP2016075A1 Thiazole derivatives and their use as anti-tumour agents |
| 01/21/2009 | EP2016074A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016068A1 Pyrazole derivatives and their use as pi3k inhibitors |
| 01/21/2009 | EP2016063A1 Thiazole derivatives as inhibitors of p13 kinase |
| 01/21/2009 | EP2016058A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
| 01/21/2009 | EP2015775A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody |
| 01/21/2009 | EP2015748A2 Method of inhibiting c kit kinase |
| 01/21/2009 | EP2015746A2 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 01/21/2009 | EP2015745A2 Macrocyclic kinase inhibitors |
| 01/21/2009 | EP2015743A2 Glutadon |
| 01/21/2009 | EP1863792B1 Atp competitive kinase inhibitors |
| 01/21/2009 | EP1664026B1 Mitotic kinesin inhibitors |
| 01/21/2009 | EP1603566B1 Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
| 01/21/2009 | EP1562939B1 Carboxamides |
| 01/21/2009 | EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
| 01/21/2009 | EP1127107B1 Methods for the production of tcr gamma delta t cells |
| 01/21/2009 | EP1019438B1 Apoptosis-related compounds and their use |
| 01/21/2009 | EP0993468B1 Compositions and methods for activating genes of interest |
| 01/21/2009 | CN101351477A Anti-CD19 antibodies with reduced immunogenicity |
| 01/21/2009 | CN101351467A 3-(substituted amino)-pyrazolo[3,4-d]pyrimidines as EphB and VEGFR2 kinase inhibitors |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101351444A Novel pyrrole derivates with histone deacetylation enzyme inhibition activity |
| 01/21/2009 | CN101351213A Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses |
| 01/21/2009 | CN101351212A Efficacity strengthening agent for replacing curative and anticancer preparation using the same |
| 01/21/2009 | CN101351211A Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 01/21/2009 | CN101351201A Pharmaceutical preparation of aqueous solution containing platinum complex |
| 01/21/2009 | CN101348812A Lichenin, and preparation and use thereof |
| 01/21/2009 | CN101348788A Cell proliferation related gene CNKSR3, screening method and use thereof |
| 01/21/2009 | CN101348569A Organotin coordination polymeric compound, preparation and use thereof |
| 01/21/2009 | CN101348521A Aminoacid mimic epitope of human B lymphocyte stimulating factor receptor and use thereof |
| 01/21/2009 | CN101348515A Use of starfish saponin compound |
| 01/21/2009 | CN101348514A Use of starfish saponin compound extracted from Culcita novaeguineae |
| 01/21/2009 | CN101348513A Ganoderic acid extraction method and preparation of soft capsule of ganoderic acid |
| 01/21/2009 | CN101348512A Antineoplastic ad virus preparation |
| 01/21/2009 | CN101348511A Synthesis and refinement of nelarabine |
| 01/21/2009 | CN101348509A 2-aryl-6-arylí»-glucoside compound, and preparation and use thereof |
| 01/21/2009 | CN101348504A Ruthenium mixed-polypyridyl complex, preparation thereof and use as antitumor drug |
| 01/21/2009 | CN101348503A O,Oí»-amino malonate and N, O-amino malonate platinum complex compound |
| 01/21/2009 | CN101348495A Thiazolo-[3,2-a] pyridine compound and use thereof as Bcl-2 family protein antagonist |
| 01/21/2009 | CN101348488A Separation and extraction method for camptothecine |
| 01/21/2009 | CN101348482A 3-amido-4-indole maleimide compound, preparation and use thereof |
| 01/21/2009 | CN101348478A Preparation of methyl bryoanthrathiophene and analogues thereof |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347626A Vascularized specific polypeptide for marking tumor by radioactive nucleus and uses thereof |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN101347616A Composing prescription of novel safe JY immunoadjuvant system and uses thereof |
| 01/21/2009 | CN101347597A Effective component of turmeric rhizome and preparation method and use thereof |
| 01/21/2009 | CN101347574A Chinese medicine for treating perineural fibroma disease |
| 01/21/2009 | CN101347567A Effective component of airpotato yam as well as preparation method and use thereof |
| 01/21/2009 | CN101347566A Effective component of airpotato yam as well as preparation method and use thereof |
| 01/21/2009 | CN101347565A Effective component of Japanese yam as well as preparation method and use thereof |
| 01/21/2009 | CN101347564A Medicine for curing carcinoma of stomach |
| 01/21/2009 | CN101347542A Prescription composition and preparation technique and use of Chinese medicine compound í«Six-dragon admixtureí» |
| 01/21/2009 | CN101347534A Effective component of gamene and preparation and use thereof |
| 01/21/2009 | CN101347533A Effective component of gamene and preparation and use thereof |
| 01/21/2009 | CN101347525A Chinese medicinal composition for dispelling bruise and dissolving tumor |
| 01/21/2009 | CN101347521A Effective component of Clematis chinensis and preparation and use thereof |